Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: Survey

Katana D2C Manufacturing in a Recession Report: Brands Gear Up for Peak Holiday Sales Period as Multitude of Manufacturers Experience Twofold Increase in Material Costs


Katana, a cloud-based inventory and manufacturing platform, today revealed the significant impact of the recession, supply chain challenges and rising material costs on direct-to-consumer (D2C) manufacturing companies during peak holiday sales periods in its new, annual report: "D2C Manufacturing in a Recession." The findings from Katana's proprietary customer survey highlight the criticality of early demand forecasting, proactive stock management and integrated digital workflows for successful sales surges in 2023. The report combines expert consumer and market research and data from real D2C manufacturers and outlines actionable insights that can support D2C manufacturers as they continue to navigate economic volatility during the holiday season.

Key findings from the survey include:

"Direct-to-consumer manufacturers are facing a mountain of challenges right now, from supply chain snarls to soaring material costs, over which they have little control," said Kristjan Vilosius, Founder and CEO, Katana. "These brands should be preparing their seasonal checklist now as staying ahead of the curve is the only way to future-proof your business. By implementing the right measures early, including using up-to-the-minute data needed to plan for success, along with proactive stock management, testing accounting and online sales workflows, and factoring in rising material costs, Katana customers have successfully navigated seasonal sales surges and unpredictability."

About the report
Katana conducted the analysis which includes more than 1,400 businesses based in North America, comprising direct-to-consumer manufacturers across nine industries, including apparel, sporting goods and toys and food and beverage. Katana's proprietary data was augmented with expert consumer and market research, alongside up-to-the-minute data sourced directly from D2C manufacturers.

About Katana
Katana's cloud manufacturing platform covers the live inventory, production, accounting and reporting features that give businesses the knowledge they need to make the right decisions. Founded in 2017, Katana's portfolio of more than 1,400 companies ranges from multi-million dollar manufacturing businesses to hobby makers, supporting over $1 billion is combined sales revenue in 2022. To date, Katana's founding team has raised more than $51 million in funding from VC firms and angel investors and scaled its team of six to 140 employees across North America, Europe, Asia, and Oceania.


These press releases may also interest you

at 21:45
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gritstone bio, Inc. between March 9, 2023 and February 29, 2024, both dates inclusive (the "Class Period"), of the important August 6, 2024 lead plaintiff...

at 17:50
The global feminine hygiene wash market  size is estimated to grow by USD 124.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 5.17%  during the forecast period.  Advertising and promotion of...

at 17:30
The global marine loading arms market size is estimated to grow by USD 65.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 3.43%  during the forecast period. Rise in demand for oil and gas...

at 17:01
The global payment gateways market size is estimated to grow by USD 11.23 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 13.42%  during the forecast period.  High adoption of contactless payment...

at 16:50
The global wellness real estate market size is estimated to grow by USD 1.26 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 32.14% during the forecast period. Rising demand for wellness real estate from...

at 16:35
Navidea Biopharmaceuticals, Inc. ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced disappointing results of an exploratory analysis conducted on the...



News published on and distributed by: